Diagnostic accuracy of fine-needle aspiration cytology in histological grade 1 breast carcinomas: are we good enough?
Introduction
Fine needle aspiration cytology (FNAC) is an integral part of the preoperative multidisciplinary triple approach in the work-up of both symptomatic and screen-detected breast lesions in many institutions. Breast FNAC of palpable and non-palpable lesions is reliable and cost-effective. The literature reports sensitivity ranging from 65% to 98% and specificity ranging from around 60% to 100%. When integrated into the assessment process, FNAC reduces the benign biopsy rate. (24) The breast cancer screening programme in Norway has caused a considerable increase in the incidence of low-grade carcinomas. The first screening rounds showed that up to 45% of detected carcinomas were histological grade 1 (25) in contrast to about 20% in symptomatic tumours. It has been generally assumed that the accuracy in diagnosing low-grade breast carcinomas on FNAC is substantially lower than in grades 2 and 3 carcinomas, resulting in a high degree of false negative diagnoses in grade 1 breast carcinomas and hence in a large proportion of screendetected breast carcinomas. Some studies have shown that a significant number of false negatives may be caused by interpretation failure of certain histological subtypes, such as invasive lobular, tubular, adenosquamous and papillary carcinomas. (26, 27) Characteristic cytological features have been described in more detail in a separate publication. (28) The aim of this study was to investigate our results of FNAC on histological grade 1 symptomatic and screen-detected breast carcinomas.
Methods
Records from 839 cases of histological grade 1 breast carcinomas diagnosed during 1996-2004 were retrieved from the files of the Department of Pathology, Ullevaal University Hospital (UUS). About one third had been preoperatively investigated outside UUS and FNAC was not available. Smears submitted from one external radiologist were omitted and only cases where the cytopathologists in our department had participated in the aspiration were primarily included. (21) Cases that on review revealed a dominant ductal carcinoma in situ (DCIS) on histology, and where it was obvious that cellular material from the DCIS component was predominant in the smears, were excluded. Lastly, the relevant diagnostic smears could not be found in two cases. This left us with FNAC from 494 histological confirmed grade 1 carcinomas. Both Papanicolaou (ethanol spray fixation) and Giemsa (air-dried and methanol-fixed) stained smears were evaluated. The general diagnostic cytological categories and criteria used in the department are given in Table 1 . Tumour size, nodal status and the presence or absence of distant metastases (TNM) and grading were taken from the pathology records. The grading had been carried out according to Elston and EllisÕ modification of Bloom and Richardson. (29, 30) The histological grading was not reviewed. The preoperative cytological diagnoses, as well as suggestion of subtypes of carcinoma were recorded. The smears were also evaluated for amount of cell material (scant, moderate or abundant), as well as for microcalcifications and myoepithelial cells. In addition, the type of error was evaluated (interpretation versus sampling error). A diagnosis of less than ÔcarcinomaÕ in good quality smears with moderately and ⁄ or abundant cellularity was evaluated as interpretation error. Suboptimal smears with any kind of technical fault (crush artefacts, improper fixation) and ⁄ or scant cellularity were regarded as sampling errors. This included smears with no or a limited number of benign-appearing epithelial cells where it was obvious that the tumour had been missed on aspiration. One observer (MK) evaluated 380 cases independently as part of a medical studentÕs project. Of these, 242 were also evaluated by joint microscopy by the two observers. Observer two (TS) evaluated the rest independently and overruled observer one in cases of discrepancies. The rest of the cases were evaluated by TS alone. As this was a studentÕs project, no inter-observer evaluation was done.
Statistical analysis
All the values analysed were in proportions. Therefore, test for difference between two proportions was calculated using the EPITABLE program of EPI INFO 6 software. Significance was taken as P £ 0.05.
Results
There were 397 (80.3%) pT1 carcinomas while 93 (18.8%) were pT2 and four (0.8%) were pT3 and pT4 combined. There were 50.1% cases without lymph node metastases, whereas 16.6% had involved nodes. Nodal status was unknown in 33.3%. An overview of the results is shown in Tables 2 and 3 . There were 24 (4.8%) false negatives (benign and probably benign) whereas 13 (2.6%) FNAs were unsatisfactory for diagnosis ( Table 2 ). Nine of 13 (69.2%) unsatisfactory FNAs were from tumours less than 1 cm in diameter (pT1a and pT1b). Three pT2 cases with unsatisfactory FNAC were all invasive lobular carcinomas. Absolute sensitivity (malignant cytology) for pT1a and pT1b tumours was 65.8% and complete sensitivity (malignant + suspicious + equivocal) was 84.4%; both significantly lower than for tumours more than 1 cm in size (P £ 0.00001).
Complete sensitivity for all cases was 92.5% (434 cases), whereas absolute sensitivity was 77.3% (382 cases). Invasive ductal carcinomas comprised 82.8% of cases (Figure 1 ). Invasive lobular and tubular carcinomas (Figures 2, 3(a) and (b) comprised 7.3% and 5.7%, respectively. Absolute sensitivity was 50.0% for invasive lobular and 57.1% for tubular carcinoma; significantly lower than for ductal and other subtypes (P £ 0.0001). The difference for complete sensitivity was less but still significant (P = 0.017).
In 397 (80.3%) cases a subtype was suggested on cytology. Whereas 92.6% of cases described as ductal on cytology were confirmed by histological subtyping, only six of 13 (46.2%) and three of five (60.0%), respectively, reported as suggestive invasive lobular and tubular carcinoma were confirmed as those subtypes. Of 16 suggested to be mucinous carcinomas 11 (68.8%) were confirmed on histology.
Sampling error was the cause of not reaching a definite diagnosis of malignancy on FNAC in 74 cases (66.1%) and in 83.3% of both invasive lobular and tubular carcinomas. Although the numbers in the latter groups were small, the difference between those and other subtypes was significant (P = 0.02). Scant cell material was found in 19.8% of cases and made up 81.2% of cases with a benign FNAC diagnosis (13 ⁄ 16), 75% of the probably benign cases (6 ⁄ 8) and 60.9% of the equivocal cases (14 ⁄ 23). These and 46.2% of the suspicious cases (24 ⁄ 52) made up the sampling errors. A definite diagnosis of malignancy was given in 10.1% of cases in spite of the scant cellularity. Abundant cell material was noted in 50.9% of the cases. None of these had been given a benign diagnosis, but 12.5% had been diagnosed as probably benign, 10% as equivocal and 18.4% as suspicious and representing interpretation errors. Scattered myoepithelial cell nuclei were found at the periphery of epithelial (carcinoma) cell groups (but not in the background) in 20.2% of ductal and 39.1% of tubular carcinomas. Microcalcifications were found in 45% of all cases (in 47% of ductal, 17.2% of invasive lobular and 65.2% of tubular carcinomas.
Discussion
Sensitivity, percentage of inadequate smears and false negatives on FNAC of grade 1 breast carcinomas are all well within the QC recommendations in the Norwegian breast screening programme. (21) The sensitivity is marginally lower than in previous results from non-palpable breast lesions. (22) This is in agreement with the fact that 80.3% of the carcinomas in this study were pT1 and the vast majority would have been non-palpable (this feature had not been recorded). In a previous report of the first 4 years of mammography screening in Oslo (21) , we found an absolute and complete sensitivity of 81% and 91%, respectively. The sensitivity of FNAC ranges in the literature from 65% to 98%. (7) This reflects both aspirator and interpretation skills. FNAC is highly operator dependent. (7, 31, 32) Aspirator skill is also reflected in the inadequacy rate, which was 2.6% in our study. Subtyping of carcinomas on cytological material revealed differences between invasive ductal, lobular and tubular carcinomas (Table 3) . Whereas 92.6% of cytology suggested as ductal carcinoma were confirmed on histology, less than half of the small number predicted as lobular or tubular were confirmed as such. Both invasive lobular and tubular carcinomas have characteristic cytological features reported in the literature, (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) but none of them are restricted to one subtype only. Invasive ductal carcinoma has a wide range of histological appearances which may be reflected in FNAC. They include features that may also be found in other subtypes. Also, ductal carcinomas may harbour components of other subtypes such as tubular, mucinous, papillary and lobular which may be found in the smears. The most important is to recognize a papillary subtype, as these may present as a tumour both clinically and radiologically and still be an in situ lesion on histology. The problem of diagnosing in situ versus invasive lesions has been addressed previously. (21, 45) In case of a cytological papillary carcinoma, we do not attempt to predict eventual invasive growth. The lesion will be resected with free margins, but the sentinel node will not be removed. Apart from that, subtyping does not affect the primary management of the women and is not essential. Sampling error was the main cause of not giving a preoperative definite malignant diagnosis irrespective of tumour type (Table 3 ) and the main cause was small tumour size (see Table 2 ). In ductal carcinomas, the causes were rather mixed and both sampling and interpretation might be a problem. Sampling is a wellknown problem in lobular carcinoma and is due to the abundant sclerotic stroma that is found in most cases. The carcinoma cells usually present with a low-grade, but recognizable atypia, and are characteristically few in numbers. The characteristic finding in FNAC from lobular carcinoma would be scant to moderate amount of cells (Table 3 ) diagnosed as suspicious (30.5%) or as malignant (50%) and where the reservation in the diagnosis is due to a low number of carcinoma cells on the smears.
Tubular carcinomas present little atypia in contrast to most ductal carcinomas and may be misdiagnosed as fibroadenoma or fibrocystic changes. (34, 35) Cellular features such as angular tubular structures, single epithelial cells, absence of or paucity of bare oval nuclei are frequently described as distinguishing features. (33, 34) In our study, tubular carcinomas represented a diagnostic problem as they frequently eluded detection on cytology. Eight (28.5%) cases were diagnosed as unsatisfactory, benign or equivocal. A definitive preoperative diagnosis (absolute sensitivity) was given in 57.1% in our study, whereas the complete sensitivity (malignant + suspicious + equivocal) was 85.7%. Mitnick et al. (43) showed an absolute sensitivity of 42%, which is somewhat lower than our findings. Cangiarella et al. (34) showed a complete sensitivity of 86%. Despite the discrete cellular and nuclear atypia of tubular carcinomas, the main cause of not reaching a definitive malignant diagnosis in our material was sampling error (Table 3) . Although there is a higher false negative rate in lobular and tubular carcinomas compared with ductal carcinoma, the combined incidence comprised only 13.2% of the total number of cases in our study. Overall, lobular carcinomas will make up a larger group, though, as many of them are diagnosed as grade 2.
There has been an increase in the use of core biopsy (CNB) in the recent years. (46, 47) CNB has a higher sensitivity for lobular and tubular carcinomas, (43) but considering the incidence, it would be cost efficient and time saving to use FNAC as a first-line investigation. Combination of CNB and FNAC has shown a higher sensitivity than FNAC alone. (12) However, if the sensitivity of FNAC is high, the additional value of a CNB will have a marginal effect on the sensitivity. In addition, sampling of small and focal lesions is known to cause diagnostic difficulties even in CNB. (48) Myoepithelial cells were found in a subpopulation of ductal and tubular carcinomas (20% and 39%, respectively), but always in limited numbers. It is important to know this and not diagnose these lesions as benign or probably benign on account of a few myoepithelial cells. Microcalcifications were a common finding in ductal and tubular carcinomas (47% and 65.2%, respectively), but were non-contributory in the diagnostic work-up.
In conclusion, FNAC had a high sensitivity in diagnosing low-grade invasive carcinomas. The main difficulties encountered were related to sampling errors, irrespective of tumour subtype. Small tumour size was the main cause of sampling errors. In contrast to what might have been expected, ductal carcinomas had the largest proportion of interpretation errors.
